MARISSA LAHART: Open Payments
NPI 1568862944 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 16 payments from 8 companies in 2025. Trend: 2023 $443 · 2024 $440 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| Merck Sharp & Dohme LLC | 2 | $56 |
| AstraZeneca Pharmaceuticals LP | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $48 |
| Stryker Corporation | 1 | $31 |
| Eisai Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: VERZENIO, KISQALI, Enhertu, KEYTRUDA, SPY-PHI SYSTEM, Lenvima, CALQUENCE, ZEJULA.
Industry payments across PA — which companies pay providers there.
